10.1096/fj.09-149997 58 LimongiD.BaldelliS.ChecconiP.MarcocciM
For researchers investigating chronic low-grade inflammation (often called inflammaging), it offers a well-characterized tool compound for studying simultaneous antioxidant and anti-inflammatory responses without the systemic suppression that comes from corticosteroids or broad NSAIDs
![A person in a light blue shirt receiving back pain relief from a physical therapist, with a spine model and tablet on the table.][image1] Alt Text: A person in a light blue shirt receiving back pain relief from a physical therapist, with a spine model and tablet on the table
Both peptides have been well-tolerated in preclinical studies, with no significant adverse effects reported at therapeutic doses
Single-vial format lets you test a compound without committing to a full sealed box, useful for short pilot protocols
Fine lines diminish as collagen and elastin networks rebuild